Insider Trading disclosures for Nexalin Technology Inc

The latest disclosure was made by Carolyn Shelton in Nexalin Technology Inc where a trade of 6,000 Common Stock done at an average price of $2.2 was reported to US exchanges on March 12, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Carolyn Shelton	Sr. VP - Quality, Regulatory	Purchase of securities on an exchange or from another person at price $ 2.20 per share.	12 Mar 2025	6,000	30,000	-	2.2	13,200	Common Stock
David Owens	Director, Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	125,000	919,184	-		-	Stock Option (right to buy)
David Owens	Director, Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	654,363	794,184	-		-	Stock Option (right to buy)
David Owens	Director, Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	139,821	139,821	-		-	Stock Option (right to buy)
Mark White	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	939,597	1,387,024	-		-	Stock Option (right to buy)
Mark White	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	447,427	447,427	-		-	Stock Option (right to buy)
David Owens	Director, Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 3.10 per share.	04 Feb 2025	1,000	155,793	-	3.1	3,100	Common stock
David Owens	Director, Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 2.98 per share.	04 Feb 2025	1,000	154,793	-	3.0	2,980	Common stock
David Owens	Director, Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 2.70 per share.	28 Jan 2025	1,500	153,793	-	2.7	4,050	Common stock
David Owens	Director, Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 2.70 per share.	13 Jan 2025	1,000	152,293	-	2.7	2,700	Common stock
David Owens	Director, Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 2.50 per share.	13 Jan 2025	2,000	151,293	-	2.5	5,000	Common stock
Carolyn Shelton	Senior VP	Purchase of securities on an exchange or from another person at price $ 0.85 per share.	31 Dec 2024	24,000	24,000	-	0.9	20,400	Common stock
Carolyn Shelton	Senior VP		31 Dec 2024	90,620	90,620	-		-	Stock Option (right to buy)
Alan Kazden	Director		31 Dec 2024	262,500	262,500	-		-	Stock Option (right to buy)
David Owens	Director, Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 2.75 per share.	31 Dec 2024	1,000	149,293	-	2.8	2,750	Common stock
David Owens	Director, Chief Medical Officer		31 Dec 2024	262,500	262,500	-		-	Stock Option (right to buy)
David Owens	Director, Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 2.19 per share.	28 Oct 2024	500	148,293	-	2.2	1,095	Common stock
Benjamin V. Hue	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2024	175,000	340,636	-		0	Common stock
Marilyn Elson	Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2024	700,000	1,535,244	-		0	Common Stock
Leslie Bernhard	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2024	49,838	49,838	-		0	Common stock
Marilyn Elson	Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Sep 2024	700,000	1,535,244	-		0	Common Stock
David Owens	Director, Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 0.95 per share.	13 Aug 2024	1,000	147,793	-	1.0	950	Common stock
David Owens	Director, Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 1.75 per share.	28 Jun 2024	1,000	146,793	-	1.8	1,750	Common stock
David Owens	Director, Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 0.71 per share.	18 Jun 2024	1,619	145,793	-	0.7	1,149	Common stock
David Owens	Director, Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 0.62 per share.	10 Jun 2024	1,000	144,174	-	0.6	620	Common stock
David Owens	Director, Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 0.65 per share.	10 Jun 2024	2,000	143,174	-	0.7	1,300	Common stock
Marilyn Elson	Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	28 Sep 2022	36,000	136,000	-		-	Common stock warrants
Marilyn Elson	Ms. Elson serves as CFO, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 1.12 per share.	28 Sep 2022	9,500	835,244	-	1.1	10,640	Common Stock
Mark White	Director, President/CEO	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	16 Sep 2022	25,000	25,000	-		-	Common stock warrants
David Owens	Director, Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	16 Sep 2022	2,500	2,500	-		-	Common stock warrants
Alan Kazden	Director	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	16 Sep 2022	2,500	2,500	-		-	Common stock warrants
Alan Kazden	Director	Purchase of securities on an exchange or from another person at price $ 4.15 per share.	16 Sep 2022	2,500	83,131	-	4.2	10,375	Common Stock
Marilyn Elson	Ms. Elson serves as CFO, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	16 Sep 2022	100,000	100,000	-		-	Common stock warrants
Marilyn Elson	Ms. Elson serves as CFO, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 4.15 per share.	16 Sep 2022	36,000	825,744	-	4.2	149,400	Common Stock
David Owens	Director, Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 4.15 per share.	16 Sep 2022	2,500	141,174	-	4.2	10,375	Common Stock
Rick J. Morad	Director	Purchase of securities on an exchange or from another person at price $ 4.15 per share.	16 Sep 2022	2,500	108,341	-	4.2	10,375	Common Stock
Mark White	Director, President/CEO	Purchase of securities on an exchange or from another person at price $ 4.15 per share.	15 Sep 2022	25,000	289,627	-	4.2	103,750	Common Stock
Mark White	Director, President/CEO	Purchase of securities on an exchange or from another person at price $ 4.15 per share.	15 Sep 2022	25,000	309,127	-	4.2	103,750	Common Stock

Showing 1 to 38 of 38 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

46.99% Fall from 52W High

Insider Trading disclosures for Nexalin Technology Inc

The latest disclosure was made by Carolyn Shelton in Nexalin Technology Inc where a trade of 6,000 Common Stock done at an average price of $2.2 was reported to US exchanges on March 12, 2025.

Screeners based on Insider Trading and SAST parameters